News

Article

Psychedelics Patient Interest Poll

Author(s):

Psychiatric Times Editors

Answer a quick question on psychedelics!

Have your patients expressed interest in psychedelics for therapeutic purposes?

Yes, patient(s) have asked me about it
No, patient(s) have not asked about it

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
ketamine
Tasphong/AdobeStock
Andrii Yalaanskyi/AdobeStock
Jorm Sangsorn/AdobeStock
RolfImages/AdobeStock
CravenA/AdobeStock
brain
Related Content
Elizabeth Wassenaar
July 2nd 2025

Ketamine Safe for the Treatment of Patients With Eating Disorders: In Conversation With Elizabeth Wassenaar, MD, MS, DFAPA, CEDS-C

Leah Kuntz Elizabeth Wassenaar, MD, MS, CEDS-S, DFAPA
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
psilocybin
June 23rd 2025

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Leah Kuntz
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
April 6th 2021

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
clinical trial
April 21st 2025

MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder

Grace Koennecke
COVID
March 11th 2025

Psilocybin Benefits Clinicians Traumatized on Front Line of COVID-19 Pandemic

Kenneth J. Bender, PharmD, MA
© 2025 MJH Life Sciences

All rights reserved.